When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

The AICR Lifestyle & Cancer Symposium addresses the most current and consequential issues regarding diet, obesity, physical activity and cancer.

The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.

The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.

A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

Are you ready to make a difference? Join our team and help us advance research, improve cancer education and provide lifesaving resources.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.

Research Projects > 2021 Grantees

Investigating the Immunologic Basis of the Obesity Paradox in Renal Cell Carcinoma

Project Description

Clear cell renal carcinoma (ccRCC) has a unexpected relationship with obesity: individuals with obesity have a higher risk of developing ccRCC, but their cancers are typically less aggressive and more likely to respond to immunotherapies (treatments that target the immune system).
Understanding how obesity affects the formation and aggressiveness of ccRCC will open the door to new therapies and new ways to monitor the disease. Dr. Hakimi proposes that obesity leads to changes in immune cells within the tumor and the adjacent fat, making ccRCC less aggressive. He will conduct parallel laboratory and patient studies to examine immune cells in tumor and fat from lean ccRCC patients and those with obesity. His discoveries will provide insights into how obesity affects immune responses to ccRCC and consequently affect RCC development, aggressiveness, and response to therapies. Understanding the obesity paradox may help guide new treatment strategies for other cancer types, too.

More News & Updates

Close